Sheng Lin

3.6k total citations
95 papers, 1.6k citations indexed

About

Sheng Lin is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sheng Lin has authored 95 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 29 papers in Oncology and 22 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sheng Lin's work include MicroRNA in disease regulation (10 papers), Head and Neck Cancer Studies (9 papers) and SARS-CoV-2 and COVID-19 Research (9 papers). Sheng Lin is often cited by papers focused on MicroRNA in disease regulation (10 papers), Head and Neck Cancer Studies (9 papers) and SARS-CoV-2 and COVID-19 Research (9 papers). Sheng Lin collaborates with scholars based in China, Hong Kong and United States. Sheng Lin's co-authors include Shaozhi Fu, Shuwei Qiu, Zifeng Wang, Tong Xiang, Ying Peng, Haixia Long, Yang Tan, Gang Lü, Dan Hu and Yimin Feng and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Sheng Lin

91 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheng Lin China 21 715 515 339 219 176 95 1.6k
Yan Long China 18 704 1.0× 336 0.7× 548 1.6× 106 0.5× 170 1.0× 59 2.2k
Heng Xu China 27 894 1.3× 440 0.9× 338 1.0× 100 0.5× 277 1.6× 86 1.9k
Mohammad Doroudian Iran 25 831 1.2× 365 0.7× 144 0.4× 127 0.6× 297 1.7× 49 1.6k
Lei Wei China 21 785 1.1× 313 0.6× 274 0.8× 137 0.6× 465 2.6× 67 2.0k
Michael H. A. Roehrl United States 21 938 1.3× 283 0.5× 424 1.3× 101 0.5× 212 1.2× 85 1.9k
Meghdad Abdollahpour‐Alitappeh Iran 22 593 0.8× 190 0.4× 550 1.6× 81 0.4× 311 1.8× 81 1.6k
Barbara Mayer Germany 23 685 1.0× 240 0.5× 644 1.9× 80 0.4× 208 1.2× 64 1.7k
Haixun Guo United States 25 1.0k 1.5× 436 0.8× 390 1.2× 81 0.4× 431 2.4× 41 1.9k
Zhe Zhang China 30 1.1k 1.6× 587 1.1× 802 2.4× 62 0.3× 207 1.2× 121 2.6k
Xiangyi Ma China 21 519 0.7× 162 0.3× 270 0.8× 59 0.3× 161 0.9× 48 1.2k

Countries citing papers authored by Sheng Lin

Since Specialization
Citations

This map shows the geographic impact of Sheng Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng Lin more than expected).

Fields of papers citing papers by Sheng Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheng Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng Lin. The network helps show where Sheng Lin may publish in the future.

Co-authorship network of co-authors of Sheng Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Sheng Lin. A scholar is included among the top collaborators of Sheng Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheng Lin. Sheng Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xu, Min, Xialin Zhang, Cheng Ma, et al.. (2025). Epigenetic and metabolic reprogramming via nanotechnology: a synergistic approach to cancer vaccination in lung tumors. Frontiers in Genetics. 16. 1666561–1666561.
2.
Yu, You, Fanli Yang, Sheng Lin, et al.. (2025). Rabies virus glycoprotein: Structure, function, and antivirals. 4(2). 67–86. 1 indexed citations
3.
4.
5.
Huang, Zhuoying, Wenjia Xiao, Sheng Lin, et al.. (2025). Rotavirus vaccine effectiveness and coverage among children younger than 5 years old in Shanghai, China: A test-negative case control study. Vaccine. 48. 126731–126731. 2 indexed citations
6.
Li, Yunfei, et al.. (2023). Research on automatic classification technology of kidney tumor and normal kidney tissue based on computed tomography radiomics. Frontiers in Oncology. 13. 1013085–1013085. 7 indexed citations
7.
Guo, Liyan, Sheng Lin, Zimin Chen, et al.. (2023). Targetable elements in SARS-CoV-2 S2 subunit for the design of pan-coronavirus fusion inhibitors and vaccines. Signal Transduction and Targeted Therapy. 8(1). 197–197. 37 indexed citations
8.
9.
Li, Xiaoyue, Huan Zhou, Hongxia Li, et al.. (2023). Risk Factors for Operation Complications of High Dose Rate 3-Dimensional Interstitial Brachytherapy for Lung Cancer. Clinical Lung Cancer. 24(5). e187–e194. 1 indexed citations
10.
Yang, Jing, Sheng Lin, Zimin Chen, et al.. (2022). A Potent Neutralizing Nanobody Targeting the Spike Receptor-Binding Domain of SARS-CoV-2 and the Structural Basis of Its Intimate Binding. Frontiers in Immunology. 13. 820336–820336. 8 indexed citations
11.
Lin, Sheng, Hua Chen, Zimin Chen, et al.. (2021). Crystal structure of SARS-CoV-2 nsp10 bound to nsp14-ExoN domain reveals an exoribonuclease with both structural and functional integrity. Nucleic Acids Research. 49(9). 5382–5392. 85 indexed citations
13.
Yang, Zheng, Huanyu Wu, Hào Pān, et al.. (2020). Pre‐symptomatic transmission of novel coronavirus in community settings. Influenza and Other Respiratory Viruses. 14(6). 610–614. 13 indexed citations
14.
Lin, Sheng, Hào Pān, Huanyu Wu, et al.. (2020). Epidemiological and clinical characteristics of 161 discharged cases with coronavirus disease 2019 in Shanghai, China. BMC Infectious Diseases. 20(1). 780–780. 6 indexed citations
15.
Lin, Xi, Fei Ye, Sheng Lin, et al.. (2019). Crystal structure of PA0833 periplasmic domain from Pseudomonas aeruginosa reveals an unexpected enlarged peptidoglycan binding pocket. Biochemical and Biophysical Research Communications. 511(4). 875–881. 4 indexed citations
16.
Pang, Haowen, Sheng Lin, Bo Yang, Jingbo Wu, & Xuejun Sun. (2019). A method for standardizing intensity modulated radiation therapy planning optimization for nasopharyngeal carcinoma. Iranian Journal of radiation research. 17(1). 177–181. 1 indexed citations
17.
Zhang, Yingjie, Zhouxue Wu, Haowen Pang, et al.. (2018). Preliminary report of a single‐channel applicator in high dose rate afterloading brachytherapy for cervical cancer. Cancer Science. 109(12). 3953–3961. 3 indexed citations
19.
Chen, Zimin, Fei Ye, Sheng Lin, et al.. (2018). Crystal structure of Usutu virus envelope protein in the pre-fusion state. Virology Journal. 15(1). 7 indexed citations
20.
Yang, Bo, Xiaoyang Sun, Haowen Pang, et al.. (2017). Dosimetric analysis of rib interference of the CTV during interstitial brachytherapy of lung tumors. Journal of Contemporary Brachytherapy. 9(6). 566–571. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026